Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05964582 · ClinicalTrials.gov registry record
Prospective Surveillance of Respiratory Syncytial Virus Disease in Infants and Toddlers
A clinical trial, sponsored by Sanofi Pasteur, a Sanofi Company.
- Completed
- Registry status
- 344
- Enrollment target
NCT05964582 is a clinical trial that has completed, run by Sanofi Pasteur, a Sanofi Company. The registered enrollment target is 344 participants.
The verdict
NCT05964582 has completed, sponsored by Sanofi Pasteur, a Sanofi Company.
- COMPLETED
- Registry status
- 344 participants
- Enrollment target
Study Summary
The study is a multi-center, multi-national, prospective surveillance study in which the study participants will not receive a study vaccine but will provide a baseline blood sample and be followed for acute respiratory disease during 6 months. The 6-month follow-up will occur for the most part during the Respiratory Syncytial Virus(RSV) season (based on enrollment timing and as per feasibility). A maximum of 1000 children from 6 to \< 22 months of age are planned to be enrolled in 5 to 10 countries, 1 to 2 sites per country, targeting approximately 100 participants per country. The purpose of the study is to assess the seroprevalence and incidence of RSV disease during the study period in the targeted countries and sites for a Phase III vaccine study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 344 participants |
| Start Date | 2023-07-11 |
| Est. Completion | 2024-07-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05964582
The ClinicalTrials.gov registry entry for NCT05964582 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 344 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi Pasteur, a Sanofi Company, which has 153 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05964582 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05964582 about?
NCT05964582 is a clinical study titled "Prospective Surveillance of Respiratory Syncytial Virus Disease in Infants and Toddlers". The study is a multi-center, multi-national, prospective surveillance study in which the study participants will not receive a study vaccine but will provide a baseline blood sample and be followed for acute respiratory disease during 6 months. The 6-month follow-up will occur for the most part duri...
What is the current status of trial NCT05964582?
This trial is currently completed. The enrollment target is 344 participants. The study started on 2023-07-11. Estimated completion is 2024-07-02.
Who is sponsoring clinical trial NCT05964582?
This trial is sponsored by Sanofi Pasteur, a Sanofi Company, which has 153 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.